BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cruz AC, Ramaswamy M, Ouyang C, Klebanoff CA, Sengupta P, Yamamoto TN, Meylan F, Thomas SK, Richoz N, Eil R, Price S, Casellas R, Rao VK, Lippincott-Schwartz J, Restifo NP, Siegel RM. Fas/CD95 prevents autoimmunity independently of lipid raft localization and efficient apoptosis induction. Nat Commun 2016;7:13895. [PMID: 28008916 DOI: 10.1038/ncomms13895] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 4.8] [Reference Citation Analysis]
Number Citing Articles
1 Lin H. Protein cysteine palmitoylation in immunity and inflammation. FEBS J. [DOI: 10.1111/febs.15728] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
2 Dhodapkar MV. Navigating the Fas lane to improved cellular therapy for cancer. J Clin Invest 2019;129:1522-3. [PMID: 30830880 DOI: 10.1172/JCI127581] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Dostert C, Grusdat M, Letellier E, Brenner D. The TNF Family of Ligands and Receptors: Communication Modules in the Immune System and Beyond. Physiological Reviews 2019;99:115-60. [DOI: 10.1152/physrev.00045.2017] [Cited by in Crossref: 76] [Cited by in F6Publishing: 86] [Article Influence: 25.3] [Reference Citation Analysis]
4 Gregory-Ksander M, Marshak-Rothstein A. The FasLane to ocular pathology-metalloproteinase cleavage of membrane-bound FasL determines FasL function. J Leukoc Biol 2021. [PMID: 33565149 DOI: 10.1002/JLB.3RI1220-834R] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Mande P, Zirak B, Ko WC, Taravati K, Bride KL, Brodeur TY, Deng A, Dresser K, Jiang Z, Ettinger R, Fitzgerald KA, Rosenblum MD, Harris JE, Marshak-Rothstein A. Fas ligand promotes an inducible TLR-dependent model of cutaneous lupus-like inflammation. J Clin Invest 2018;128:2966-78. [PMID: 29889098 DOI: 10.1172/JCI98219] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
6 Kurma K, Boizard-Moracchini A, Galli G, Jean M, Vacher P, Blanco P, Legembre P. Soluble CD95L in cancers and chronic inflammatory disorders, a new therapeutic target? Biochim Biophys Acta Rev Cancer 2021;1876:188596. [PMID: 34324950 DOI: 10.1016/j.bbcan.2021.188596] [Reference Citation Analysis]
7 Voss K, Lake C, Luthers CR, Lott NM, Dorjbal B, Arjunaraja S, Bauman BM, Soltis AR, Sukumar G, Dalgard CL, Snow AL. FOXP3 protects conventional human T cells from premature restimulation-induced cell death. Cell Mol Immunol 2021;18:194-205. [PMID: 31659245 DOI: 10.1038/s41423-019-0316-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
8 Leonardi AJ, Proenca RB. Akt-Fas to Quell Aberrant T Cell Differentiation and Apoptosis in Covid-19. Front Immunol 2020;11:600405. [PMID: 33408715 DOI: 10.3389/fimmu.2020.600405] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Nguyen HT, Guégan JP, Poissonnier A, Jouan F, Best D, van de Weghe P, Vacher P, Levoin N, Legembre P, Jean M. Synthesis of peptidomimetics and chemo-biological tools for CD95/PLCγ1 interaction analysis. Bioorg Med Chem Lett 2019;29:2094-9. [PMID: 31301931 DOI: 10.1016/j.bmcl.2019.07.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Wallach D, Kang TB. Programmed Cell Death in Immune Defense: Knowledge and Presumptions. Immunity 2018;49:19-32. [PMID: 30021143 DOI: 10.1016/j.immuni.2018.06.019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
11 Yi F, Frazzette N, Cruz AC, Klebanoff CA, Siegel RM. Beyond Cell Death: New Functions for TNF Family Cytokines in Autoimmunity and Tumor Immunotherapy. Trends Mol Med 2018;24:642-53. [PMID: 29880309 DOI: 10.1016/j.molmed.2018.05.004] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 8.5] [Reference Citation Analysis]
12 Lafont E. Stress Management: Death Receptor Signalling and Cross-Talks with the Unfolded Protein Response in Cancer. Cancers (Basel) 2020;12:E1113. [PMID: 32365592 DOI: 10.3390/cancers12051113] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
13 Tang W, Wang H, Tian R, Saret S, Cheon H, Claudio E, Siebenlist U. Bcl-3 inhibits lupus-like phenotypes in BL6/lpr mice. Eur J Immunol 2021;51:197-205. [PMID: 32652549 DOI: 10.1002/eji.202048584] [Reference Citation Analysis]
14 Cheng CL, Chao WT, Li YH, Ou YC, Wang SS, Chiu KY, Yuan SY. Escin induces apoptosis in human bladder cancer cells: An in vitro and in vivo study. Eur J Pharmacol 2018;840:79-88. [PMID: 30287153 DOI: 10.1016/j.ejphar.2018.09.033] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
15 Bansal R, Reshef R. Revving the CAR - Combination strategies to enhance CAR T cell effectiveness. Blood Rev 2021;45:100695. [PMID: 32402724 DOI: 10.1016/j.blre.2020.100695] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
16 Wang Y, Lu H, Fang C, Xu J. Palmitoylation as a Signal for Delivery. In: Xu J, editor. Regulation of Cancer Immune Checkpoints. Singapore: Springer; 2020. pp. 399-424. [DOI: 10.1007/978-981-15-3266-5_16] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
17 Yang C, Yang Y, Ma L, Zhang GX, Shi FD, Yan Y, Chang G. Study of the cytological features of bone marrow mesenchymal stem cells from patients with neuromyelitis optica. Int J Mol Med 2019;43:1395-405. [PMID: 30628649 DOI: 10.3892/ijmm.2019.4056] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
18 Klebanoff CA, Crompton JG, Leonardi AJ, Yamamoto TN, Chandran SS, Eil RL, Sukumar M, Vodnala SK, Hu J, Ji Y, Clever D, Black MA, Gurusamy D, Kruhlak MJ, Jin P, Stroncek DF, Gattinoni L, Feldman SA, Restifo NP. Inhibition of AKT signaling uncouples T cell differentiation from expansion for receptor-engineered adoptive immunotherapy. JCI Insight 2017;2:95103. [PMID: 29212954 DOI: 10.1172/jci.insight.95103] [Cited by in Crossref: 71] [Cited by in F6Publishing: 64] [Article Influence: 14.2] [Reference Citation Analysis]
19 Huang X, Xiao S, Zhu X, Yu Y, Cao M, Zhang X, Li S, Zhu W, Wu F, Zheng X, Jin L, Xie C, Huang X, Zou P, Li X, Cui R. miR-196b-5p-mediated downregulation of FAS promotes NSCLC progression by activating IL6-STAT3 signaling. Cell Death Dis 2020;11:785. [PMID: 32963220 DOI: 10.1038/s41419-020-02997-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
20 Flores-Mendoza G, Rodríguez-Rodríguez N, Rubio RM, Madera-Salcedo IK, Rosetti F, Crispín JC. Fas/FasL Signaling Regulates CD8 Expression During Exposure to Self-Antigens. Front Immunol 2021;12:635862. [PMID: 33841416 DOI: 10.3389/fimmu.2021.635862] [Reference Citation Analysis]
21 Zhou Y, Leng X, Mo C, Zou Q, Liu Y, Wang Y. The p53 effector Perp mediates the persistence of CD4+ effector memory T-cell undergoing lymphopenia-induced proliferation. Immunol Lett 2020;224:14-20. [PMID: 32473185 DOI: 10.1016/j.imlet.2020.05.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Yamamoto TN, Lee PH, Vodnala SK, Gurusamy D, Kishton RJ, Yu Z, Eidizadeh A, Eil R, Fioravanti J, Gattinoni L, Kochenderfer JN, Fry TJ, Aksoy BA, Hammerbacher JE, Cruz AC, Siegel RM, Restifo NP, Klebanoff CA. T cells genetically engineered to overcome death signaling enhance adoptive cancer immunotherapy. J Clin Invest 2019;129:1551-65. [PMID: 30694219 DOI: 10.1172/JCI121491] [Cited by in Crossref: 57] [Cited by in F6Publishing: 38] [Article Influence: 19.0] [Reference Citation Analysis]
23 Lanyon-Hogg T, Faronato M, Serwa RA, Tate EW. Dynamic Protein Acylation: New Substrates, Mechanisms, and Drug Targets. Trends Biochem Sci 2017;42:566-81. [PMID: 28602500 DOI: 10.1016/j.tibs.2017.04.004] [Cited by in Crossref: 65] [Cited by in F6Publishing: 64] [Article Influence: 13.0] [Reference Citation Analysis]
24 Zhang Y, Zhang L, Yu C, Du X, Liu X, Liu J, An X, Wang J, Song Y, Li G, Cao B. Effects of interferon tau on endometrial epithelial cells in caprine in vitro. Gene Expr Patterns 2017;25-26:142-8. [PMID: 28669683 DOI: 10.1016/j.gep.2017.06.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
25 Comrie WA, Lenardo MJ. Molecular Classification of Primary Immunodeficiencies of T Lymphocytes. Adv Immunol 2018;138:99-193. [PMID: 29731008 DOI: 10.1016/bs.ai.2018.02.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
26 Gülcüler Balta GS, Monzel C, Kleber S, Beaudouin J, Balta E, Kaindl T, Chen S, Gao L, Thiemann M, Wirtz CR, Samstag Y, Tanaka M, Martin-villalba A. 3D Cellular Architecture Modulates Tyrosine Kinase Activity, Thereby Switching CD95-Mediated Apoptosis to Survival. Cell Reports 2019;29:2295-2306.e6. [DOI: 10.1016/j.celrep.2019.10.054] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
27 Rossin A, Miloro G, Hueber AO. TRAIL and FasL Functions in Cancer and Autoimmune Diseases: Towards an Increasing Complexity. Cancers (Basel) 2019;11:E639. [PMID: 31072029 DOI: 10.3390/cancers11050639] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
28 Fritsch J, Särchen V, Schneider-Brachert W. Regulation of Death Receptor Signaling by S-Palmitoylation and Detergent-Resistant Membrane Micro Domains-Greasing the Gears of Extrinsic Cell Death Induction, Survival, and Inflammation. Cancers (Basel) 2021;13:2513. [PMID: 34063813 DOI: 10.3390/cancers13112513] [Reference Citation Analysis]
29 Yang X, Chatterjee V, Ma Y, Zheng E, Yuan SY. Protein Palmitoylation in Leukocyte Signaling and Function. Front Cell Dev Biol 2020;8:600368. [PMID: 33195285 DOI: 10.3389/fcell.2020.600368] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]